Top Markets
Coin of the day
Eusol Biotech Co.,Ltd. Eusol Biotech Co.,Ltd.

Eusol Biotech Co.,Ltd.

6652
Rank in Stocks #33033
Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the... Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the discovery and advancement of innovative biotechnological treatments for various sleep-related conditions. Its current development portfolio showcases two key candidates: ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) designed to restore and repair neuronal function; and SM-1, a singular capsule formulation that combines three commercially available sedative medications. The company commenced operations in 1994 and maintains its principal offices in Taipei, Taiwan.
Share Price
$0.06232609
Last synced: 2026-04-09
Market Cap
$8.54M
Change (1 day)
-12.89%
Change (1 year)
-68.75%
Country
TW
Trade Eusol Biotech Co.,Ltd. (6652)

Category

P/B ratio for Eusol Biotech Co.,Ltd. (6652)
P/B ratio as of 2026 TTM: 0
According to Eusol Biotech Co.,Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Eusol Biotech Co.,Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE